Quest Diagnostics CEO Sells 10,000 Shares in June 2026—No Big Impact on Stock
Quest Diagnostics CEO sells 10,000 shares in a routine 10‑b5‑1 plan – no market shock, steady fundamentals and predictable liquidity strategy.
3 minutes to read
QUEST DIAGNOSTICS INC
Quest Diagnostics CFO Buys Shares Amid Strong Earnings & Insider Confidence
Quest Diagnostics CFO’s fresh buy amid a strong earnings surge signals insider confidence, underscoring the company’s growth plans in automation and analytics.
4 minutes to read
Quest Diagnostics Insider Sale: What Catherine Doherty’s Trade Means for Shareholders
Quest Diagnostics insider sale by EVP Catherine Doherty: routine tax‑planning moves amid steady growth, no price impact, and a continued confidence signal for shareholders.
4 minutes to read
Quest Diagnostics Executives’ RSU Sales Show Strong Confidence and Market Alignment
Executive equity moves at Quest Diagnostics reveal disciplined RSU handling, high‑level shareholder confidence, and market‑positive signals for investors and clinicians alike.
4 minutes to read
Quest Diagnostics Insider Buys Signal Confidence: What Investors Should Know
Insightful guide on how Patrick Plewman’s discounted insider purchase signals confidence in Quest Diagnostics, plus key trends shaping the diagnostics industry.
5 minutes to read